Literature DB >> 6432131

Diabetogenic effects of nifedipine.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432131      PMCID: PMC1442454          DOI: 10.1136/bmj.289.6442.437-c

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  6 in total

1.  The significance of calcium for glucose stimulation of insulin release.

Authors:  B Hellman
Journal:  Endocrinology       Date:  1975-08       Impact factor: 4.736

2.  Lack of hormonal effects of a single dose of nifedipine in healthy young men.

Authors:  B I Joffe; J M Lamprey; R Shires; S Baker; M Viljoen; H C Seftel
Journal:  J Cardiovasc Pharmacol       Date:  1983 Jul-Aug       Impact factor: 3.105

3.  Hyperglycaemic effect of nifedipine.

Authors:  S Charles; J M Ketelslegers; M Buysschaert; A E Lambert
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-04

4.  The effects of nifedipine and hydralazine induced hypotension on sympathetic activity.

Authors:  M B Murphy; A J Scriven; M J Brown; R Causon; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Impairment of insulin secretion in man by nifedipine.

Authors:  D Giugliano; R Torella; F Cacciapuoti; S Gentile; M Verza; M Varricchio
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

6.  Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients.

Authors:  T Donnelly; A D Harrower
Journal:  Curr Med Res Opin       Date:  1980       Impact factor: 2.580

  6 in total
  2 in total

1.  Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.

Authors:  T Hedner; D Elmfeldt; H Von Schenck; E Sjögren; U Smith
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

2.  Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.

Authors:  K P Ohman; L Weiner; H von Schenck; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.